Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry R Smith

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Molecular Neuroscience : MN|April 27, 2012
Small molecule anticonvulsant agents with potent in vitro neuroprotectionDouglas E Brenneman, Garry R Smith, Yan Zhang, et al.
Molecules (Basel, Switzerland)|April 16, 2020
Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANATroy E Messick, Lois Tolvinski, Edward R Zartler, et al.
Neuropharmacology|April 18, 2016
Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activatorRyan A Gregg, Callum Hicks, Sunil U Nayak, et al.
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
ACS Combinatorial Science|June 18, 2016
High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor ChemotypesKristin M Bompiani, Dejan Caglič, Michelle C Krutein, et al.
Carbohydrate Research|May 10, 2015
Synthesis of lemonose derivatives: methyl 4-amino-3-O,4-N-carbonyl-2,4,6-trideoxy-3-C-methyl-α-l-lyxo-pyranoside and its phenyl thioglycosideAlicia C Briegel, Adrienne K Cummings, Garry R Smith, et al.
Psychopharmacology|March 3, 2017
Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)Callum Hicks, Ryan A Gregg, Sunil U Nayak, et al.
ACS Chemical Neuroscience|March 31, 2018
Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in RatsCallum Hicks, Peng Huang, Linnet Ramos, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Optimization of Benzoic Acid Inhibitors Targeting the EBNA1 DNA-Binding InterfaceGarry R Smith, Mark E McDonnell, Yan Zhang, et al.
Neuropharmacology|December 16, 2014
Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebratesAlexandre Vouga, Ryan A Gregg, Maryah Haidery, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Molecular Neuroscience : MN|April 27, 2012
Small molecule anticonvulsant agents with potent in vitro neuroprotectionDouglas E Brenneman, Garry R Smith, Yan Zhang, et al.
Molecules (Basel, Switzerland)|April 16, 2020
Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANATroy E Messick, Lois Tolvinski, Edward R Zartler, et al.
Neuropharmacology|April 18, 2016
Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activatorRyan A Gregg, Callum Hicks, Sunil U Nayak, et al.
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
ACS Combinatorial Science|June 18, 2016
High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor ChemotypesKristin M Bompiani, Dejan Caglič, Michelle C Krutein, et al.
Carbohydrate Research|May 10, 2015
Synthesis of lemonose derivatives: methyl 4-amino-3-O,4-N-carbonyl-2,4,6-trideoxy-3-C-methyl-α-l-lyxo-pyranoside and its phenyl thioglycosideAlicia C Briegel, Adrienne K Cummings, Garry R Smith, et al.
Psychopharmacology|March 3, 2017
Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)Callum Hicks, Ryan A Gregg, Sunil U Nayak, et al.
ACS Chemical Neuroscience|March 31, 2018
Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in RatsCallum Hicks, Peng Huang, Linnet Ramos, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Design and Optimization of Benzoic Acid Inhibitors Targeting the EBNA1 DNA-Binding InterfaceGarry R Smith, Mark E McDonnell, Yan Zhang, et al.
Neuropharmacology|December 16, 2014
Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebratesAlexandre Vouga, Ryan A Gregg, Maryah Haidery, et al.
Pageof 3